GL1X · GenesisL1 explorer

Ligand · E17

E17 · N-{(1S,2S)-1-benzyl-3-[(4R)-5,5-dimethyl-4-{[(1R)-1,2,2-trimethylpropyl]carbamoyl}-1,3-thiazolidin-3-yl]-2-hydroxy-3-oxopropyl}-3-methyl-N~2~-{(2S)-2-[(morpholin-4-ylacetyl)amino]-2-phenylacetyl}-L-valinamide

E17, N-{(1S,2S)-1-benzyl-3-[(4R)-5,5-dimethyl-4-{[(1R)-1,2,2-trimethylpropyl]carbamoyl}-1,3-thiazolidin-3-yl]-2-hydroxy-3-oxopropyl}-3-methyl-N~2~-{(2S)-2-[(morpholin-4-ylacetyl)amino]-2-phenylacetyl}-L-valinamide (C42 H62 N6 O7 S, 795.0…

Component
E17
Formula
C42 H62 N6 O7 S
Class
ligand
Structures
2
PDB entries
1

Binding sites

E17 in 2 structures; the first of them:

  • 3LIX · crystal structure of htlv protease complexed with the inhibitor KNI-10729 · E17 B117 · binds ARG10, ASP32, GLY34, ALA35, ASP36, MET37, VAL39, VAL56 and 23 more
  • 3LIX · Crystal structure of HTLV protease complexed with the inhibitor kni- 10729 · E17 B117 · binds ARG10, ASP32, GLY34, ALA35, ASP36, MET37, VAL39, VAL56 and 23 more

Residues it binds most

LEU 2, ALA 2, ASP 2, GLY 2, VAL 2, ARG 2, ILE 2, MET 2, GLN 2, PHE 2 (residue and the binding sites it lines).

Found with

  • ZN · Zinc ion

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.